These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

147 related items for PubMed ID: 31058394

  • 1. Haematological adverse effects associated with linezolid in patients with drug-resistant tuberculosis: an exploratory study.
    Letswee G, Kamau H, Gaida R, Truter I.
    Int J Pharm Pract; 2019 Dec; 27(6):575-577. PubMed ID: 31058394
    [Abstract] [Full Text] [Related]

  • 2. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
    Rose PC, Hallbauer UM, Seddon JA, Hesseling AC, Schaaf HS.
    Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
    [Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics, optimal dosing, and safety of linezolid in children with multidrug-resistant tuberculosis: Combined data from two prospective observational studies.
    Garcia-Prats AJ, Schaaf HS, Draper HR, Garcia-Cremades M, Winckler J, Wiesner L, Hesseling AC, Savic RM.
    PLoS Med; 2019 Apr; 16(4):e1002789. PubMed ID: 31039153
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Adverse drug reactions due to linezolid in the programmatic management of drug-resistant tuberculosis in India: A retrospective multicenter study.
    Mishra G, Alffenaar JW, Munje R, Khateeb S.
    Indian J Tuberc; 2024 Apr; 71 Suppl 1():S101-S109. PubMed ID: 39067941
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Linezolid use for treatment of multidrug-resistant and extensively drug-resistant tuberculosis, New York City, 2000-06.
    Anger HA, Dworkin F, Sharma S, Munsiff SS, Nilsen DM, Ahuja SD.
    J Antimicrob Chemother; 2010 Apr; 65(4):775-83. PubMed ID: 20150181
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Peripheral neuropathy in a diabetic child treated with linezolid for multidrug-resistant tuberculosis: a case report and review of the literature.
    Swaminathan A, du Cros P, Seddon JA, Mirgayosieva S, Asladdin R, Dusmatova Z.
    BMC Infect Dis; 2017 Jun 12; 17(1):417. PubMed ID: 28606115
    [Abstract] [Full Text] [Related]

  • 13. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
    Schnippel K, Berhanu RH, Black A, Firnhaber C, Maitisa N, Evans D, Sinanovic E.
    BMC Infect Dis; 2016 Oct 21; 16(1):593. PubMed ID: 27769174
    [Abstract] [Full Text] [Related]

  • 14. Safety of longer linezolid regimen in children with drug-resistant tuberculosis and extensive tuberculosis in Southwest China.
    Zhang Z, Cheng Z, Liu Q, Shang T, Jiang L, Fu Z, Zhu K, Wang X, Chen J, Xu H.
    J Glob Antimicrob Resist; 2020 Jun 21; 21():375-379. PubMed ID: 31593796
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety profile of linezolid in the treatment of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis: a systematic review and meta-analysis.
    Agyeman AA, Ofori-Asenso R.
    Ann Clin Microbiol Antimicrob; 2016 Jun 22; 15(1):41. PubMed ID: 27334498
    [Abstract] [Full Text] [Related]

  • 16. Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients.
    Koh WJ, Kang YR, Jeon K, Kwon OJ, Lyu J, Kim WS, Shim TS.
    J Antimicrob Chemother; 2012 Jun 22; 67(6):1503-7. PubMed ID: 22403262
    [Abstract] [Full Text] [Related]

  • 17. The impact of adverse events on health-related quality of life among patients receiving treatment for drug-resistant tuberculosis in Johannesburg, South Africa.
    Sineke T, Evans D, Schnippel K, van Aswegen H, Berhanu R, Musakwa N, Lönnmark E, Long L, Rosen S.
    Health Qual Life Outcomes; 2019 May 31; 17(1):94. PubMed ID: 31151398
    [Abstract] [Full Text] [Related]

  • 18. Linezolid toxicity in patients with drug-resistant tuberculosis: a prospective cohort study.
    Wasserman S, Brust JCM, Abdelwahab MT, Little F, Denti P, Wiesner L, Gandhi NR, Meintjes G, Maartens G.
    J Antimicrob Chemother; 2022 Mar 31; 77(4):1146-1154. PubMed ID: 35134182
    [Abstract] [Full Text] [Related]

  • 19. Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules.
    Bolhuis MS, van der Werf TS, Kerstjens HAM, de Lange WCM, Alffenaar JC, Akkerman OW.
    Eur Respir J; 2019 Dec 31; 54(6):. PubMed ID: 31439686
    [No Abstract] [Full Text] [Related]

  • 20. Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients.
    Hughes J, Isaakidis P, Andries A, Mansoor H, Cox V, Meintjes G, Cox H.
    Eur Respir J; 2015 Jul 31; 46(1):271-4. PubMed ID: 25837033
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.